Journal of Tuberculosis and Lung Disease ›› 2022, Vol. 3 ›› Issue (6): 463-468.doi: 10.19983/j.issn.2096-8493.20220098
• Original Articles • Previous Articles Next Articles
Huang Yao, Fan Yuzheng, Wang Xiangyu, Zhong Tao, Zhang Jie, Yang Nansen, Li Shengbin, Ye Xuetian, Liu Shengyuan()
Received:
2022-06-06
Online:
2022-12-20
Published:
2022-12-15
Contact:
Liu Shengyuan
E-mail:liushenglb@126.com
Supported by:
CLC Number:
Huang Yao, Fan Yuzheng, Wang Xiangyu, Zhong Tao, Zhang Jie, Yang Nansen, Li Shengbin, Ye Xuetian, Liu Shengyuan. Analysis of management and treatment effects of pulmonary tuberculosis patients in Nanshan District, Shenzhen City, 2011—2020[J]. Journal of Tuberculosis and Lung Disease , 2022, 3(6): 463-468. doi: 10.19983/j.issn.2096-8493.20220098
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.jtbld.cn/EN/10.19983/j.issn.2096-8493.20220098
年份 | 户籍人口 | 非户籍人口 | 合计 | ||||||
---|---|---|---|---|---|---|---|---|---|
登记 例数 | 人口数 | 登记率 (/10万) | 登记 例数 | 人口数 | 登记率 (/10万) | 登记 例数 | 人口数 | 登记率 (/10万) | |
2011 | 86 | 549191 | 15.66 | 486 | 550722 | 88.25 | 572 | 1099913 | 52.00 |
2012 | 67 | 616048 | 10.88 | 418 | 492473 | 84.88 | 485 | 1108521 | 43.75 |
2013 | 48 | 671708 | 7.15 | 387 | 447377 | 86.50 | 435 | 1119085 | 38.87 |
2014 | 49 | 710260 | 6.90 | 398 | 425618 | 93.51 | 447 | 1135878 | 39.35 |
2015 | 55 | 755919 | 7.28 | 383 | 535233 | 71.56 | 438 | 1291152 | 33.92 |
2016 | 83 | 810194 | 10.24 | 414 | 546113 | 75.81 | 497 | 1356307 | 36.64 |
2017 | 131 | 894405 | 14.65 | 600 | 530156 | 113.17 | 731 | 1424561 | 51.31 |
2018 | 154 | 921557 | 16.71 | 459 | 572074 | 80.23 | 613 | 1493631 | 41.04 |
2019 | 146 | 980043 | 14.90 | 464 | 565745 | 82.02 | 610 | 1545788 | 39.46 |
2020 | 175 | 857936 | 20.40 | 383 | 946241 | 40.48 | 558 | 1804177 | 30.93 |
总计 | 994 | 7767261 | 12.80 | 4392 | 5611752 | 78.26 | 5386 | 13379013 | 40.26 |
年份 | 登记 总例数 | 病原学阳性 | 病原学阴性 | 无病原学结果 | |||||
---|---|---|---|---|---|---|---|---|---|
未痰检 | 结核性胸膜炎 | ||||||||
登记 例数 | 构成比 (%) | 登记 例数 | 构成比 (%) | 登记 例数 | 构成比 (%) | 登记 例数 | 构成比 (%) | ||
2011 | 572 | 283 | 49.48 | 288 | 50.35 | 0 | 0.00 | 1 | 0.17 |
2012 | 485 | 236 | 48.66 | 240 | 49.48 | 0 | 0.00 | 9 | 1.86 |
2013 | 435 | 221 | 50.80 | 209 | 48.05 | 0 | 0.00 | 5 | 1.15 |
2014 | 447 | 196 | 43.85 | 239 | 53.47 | 0 | 0.00 | 12 | 2.68 |
2015 | 438 | 203 | 46.35 | 219 | 50.00 | 0 | 0.00 | 16 | 3.65 |
2016 | 497 | 232 | 46.68 | 220 | 44.27 | 0 | 0.00 | 45 | 9.05 |
2017 | 731 | 390 | 53.35 | 298 | 40.77 | 11 | 1.50 | 32 | 4.38 |
2018 | 613 | 332 | 54.16 | 233 | 38.01 | 11 | 1.79 | 37 | 6.04 |
2019 | 610 | 367 | 60.16 | 210 | 34.43 | 8 | 1.31 | 25 | 4.10 |
2020 | 558 | 325 | 58.24 | 180 | 32.26 | 17 | 3.05 | 36 | 6.45 |
总计 | 5386 | 2785 | 51.71 | 2336 | 43.37 | 47 | 0.87 | 218 | 4.05 |
年龄组 (岁) | 合计 | 户籍人口 | 非户籍人口 | |||
---|---|---|---|---|---|---|
登记例数 | 构成比(%) | 登记例数 | 构成比(%) | 登记例数 | 构成比(%) | |
0~14 | 15 | 0.28 | 4 | 0.40 | 11 | 0.25 |
15~24 | 1411 | 26.20 | 191 | 19.22 | 1220 | 27.78 |
25~34 | 2110 | 39.18 | 364 | 36.62 | 1746 | 39.75 |
35~44 | 752 | 13.96 | 184 | 18.51 | 568 | 12.93 |
45~54 | 574 | 10.66 | 131 | 13.18 | 443 | 10.09 |
55~64 | 320 | 5.94 | 58 | 5.84 | 262 | 5.97 |
≥65 | 204 | 3.78 | 62 | 6.23 | 142 | 3.23 |
总计 | 5386 | 100.00 | 994 | 100.00 | 4392 | 100.00 |
年份 | 登记例数 | 治疗成功例数 | 诊断变更例数 | 转入耐多药治疗例数 | 治疗成功率(%) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
户籍 人口 | 非户籍 人口 | 全人口 | 户籍 人口 | 非户籍 人口 | 全人口 | 户籍 人口 | 非户籍 人口 | 全人口 | 户籍 人口 | 非户籍 人口 | 全人口 | 户籍 人口 | 非户籍 人口 | 全人口 | |
2011 | 86 | 486 | 572 | 78 | 449 | 527 | 1 | 4 | 5 | 3 | 2 | 5 | 95.12 | 93.54 | 93.77 |
2012 | 67 | 418 | 485 | 64 | 366 | 430 | 1 | 1 | 2 | 0 | 7 | 7 | 96.97 | 89.27 | 90.34 |
2013 | 48 | 387 | 435 | 45 | 348 | 393 | 0 | 10 | 10 | 1 | 5 | 6 | 95.74 | 93.55 | 93.79 |
2014 | 49 | 398 | 447 | 45 | 343 | 388 | 0 | 10 | 10 | 0 | 8 | 8 | 91.84 | 90.26 | 90.44 |
2015 | 55 | 383 | 438 | 52 | 328 | 380 | 1 | 1 | 2 | 1 | 10 | 11 | 98.11 | 88.17 | 89.41 |
2016 | 83 | 414 | 497 | 73 | 349 | 422 | 3 | 5 | 8 | 2 | 9 | 11 | 93.59 | 87.25 | 88.28 |
2017 | 131 | 600 | 731 | 122 | 536 | 658 | 0 | 4 | 4 | 0 | 16 | 16 | 93.13 | 92.41 | 92.55 |
2018 | 154 | 459 | 613 | 139 | 399 | 538 | 2 | 10 | 12 | 7 | 7 | 14 | 95.86 | 90.27 | 91.65 |
2019 | 146 | 464 | 610 | 132 | 406 | 538 | 4 | 10 | 14 | 3 | 6 | 9 | 94.96 | 90.63 | 91.65 |
2020 | 175 | 383 | 558 | 161 | 345 | 506 | 3 | 7 | 10 | 2 | 5 | 7 | 94.71 | 92.99 | 93.53 |
总计 | 994 | 4392 | 5386 | 911 | 3869 | 4780 | 15 | 62 | 77 | 19 | 75 | 94 | 94.90 | 90.93 | 91.66 |
[1] |
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990—2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet,2020, 396(10258):1204-1222. doi:10.1016/S0140-6736(20)30925-9.
doi: 10.1016/S0140-6736(20)30925-9 URL |
[2] |
张黎明. 结核病分级诊疗和综合防治服务模式在结核病防治中的效果探讨. 智慧健康, 2021, 7(13):29-31. doi:10.19335/j.cnki.2096-1219.2021.13.009.
doi: 10.19335/j.cnki.2096-1219.2021.13.009 URL |
[3] |
Jeremiah C, Petersen E, Nantanda R, et al. The WHO Global Tuberculosis 2021 Report-not so good news and turning the tide back to End TB.Int J Infect Dis, 2022:S1201- 9712(22)00149-7. doi:10.1016/j.ijid.2022.03.011.
doi: 10.1016/j.ijid.2022.03.011 URL |
[4] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017 结核病分类. 2017-11-09. |
[5] | 中华人民共和国国家卫生健康委员会办公厅. 中国结核病预防控制工作技术规范(2020年版).国卫办疾控函〔2020〕279号. 2020-04-02. |
[6] |
钟涛, 赵锦, 王健, 等. 深圳市南山区2001—2010年登记的活动性肺结核病人管理与治疗效果分析. 中国社会医学杂志, 2013, 30(2):133-135. doi:10.3969/j.issn.1673-5625.2013.02.023.
doi: 10.3969/j.issn.1673-5625.2013.02.023 URL |
[7] |
陈蕊明, 彭东东, 纪丽微, 等. 2011—2015年广东省汕头市结核病流行病学特征及DOTS策略评价. 实用预防医学, 2017, 24(5):602-604. doi:10.3969/j.issn.1006-3110.2017.05.026.
doi: 10.3969/j.issn.1006-3110.2017.05.026 URL |
[8] | 深圳市卫生和计划生育委员会. 深圳市肺结核病归口管治办法.2014-04-30. |
[9] | 中华人民共和国国家卫生和计划生育委员会办公厅. 国家卫生计生委办公厅关于开展结核病分级诊疗和综合防治服务模式试点工作的通知.国卫办疾控函〔2016〕672号. 2016-06-24. |
[10] | 端木宏谨, 王黎霞. 中国结核病控制的可持续发展问题的探讨. 中国防痨杂志, 1999, 21(2):7-8. |
[11] |
Fei H, Yinyin X, Hui C, et al. The impact of the COVID-19 epidemic on tuberculosis control in China. Lancet Reg Health West Pac, 2020, 3:100032. doi:10.1016/j.lanwpc.2020.100032.
doi: 10.1016/j.lanwpc.2020.100032 URL |
[12] | 马剑平, 钟涛, 郭旭君, 等. 深圳市南山区结核病分级诊疗实践与探索. 中国医院管理, 2020, 40(7):92-93. |
[13] |
严新凤, 秦玉宝, 陈智聪, 等. 深圳市龙华新区流动人口肺结核患者来源分析. 中国防痨杂志, 2015, 37(9):987-991. doi:10.3969/j.issn.1000-6621.2015.09.016.
doi: 10.3969/j.issn.1000-6621.2015.09.016 URL |
[14] |
钟涛, 刘盛元, 詹广兴, 等. 2005—2016年深圳市南山区肺结核流行特征分析. 疾病监测, 2018, 33(9):724-727. doi:10.3784/j.issn.1003-9961.2018.09.006.
doi: 10.3784/j.issn.1003-9961.2018.09.006 URL |
[15] |
徐光明, 叶小红, 张震, 等. 2009—2018年临海市肺结核流行特征. 预防医学, 2021, 33(1):49-51. doi:10.19485/j.cnki.issn2096-5087.2021.01.011.
doi: 10.19485/j.cnki.issn2096-5087.2021.01.011 URL |
[16] | 中华人民共和国卫生部, 中华人民共和国教育部. 关于印发《学校结核病防控工作规范(试行)》的通知. 卫办疾控发〔2010〕133号. 2010-07-01. |
[17] | 国家卫生计生委办公厅, 教育部办公厅. 学校结核病防控工作规范(2017版).国卫办疾控函〔2017〕22号. 2017-06-26. |
[18] |
张洁, 樊惠霞, 张海燕, 等. 初治涂阳肺结核治疗2个月末痰菌未转阴的影响因素研究. 宁夏医学杂志, 2016, 38(5): 433-436. doi:10.13621/j.1001-5949.2016.05.0433.
doi: 10.13621/j.1001-5949.2016.05.0433 URL |
[19] |
王慧, 许婕, 陈可, 等. 2012—2017年扬州市结核病流行特征与患者治疗转归分析. 南通大学学报(医学版), 2019, 39(5): 394-396. doi:10.16424/j.cnki.cn32-1807/r.2019.05.016.
doi: 10.16424/j.cnki.cn32-1807/r.2019.05.016 URL |
[20] |
梁爽, 韩东伟, 钟威, 等. 抗结核固定剂量复合制剂联合左氧氟沙星治疗复治涂阳肺结核患者的效果分析. 结核病与肺部健康杂志, 2019, 8(2):149-152. doi:10.3969/j.issn.2095-3755.2019.02.016.
doi: 10.3969/j.issn.2095-3755.2019.02.016 URL |
[21] |
叶海明, 陈文思, 张菊芳, 等. 深圳市福田区结核病分级诊疗和综合防治服务模式试点工作效果分析. 中国防痨杂志, 2019, 41(8):900-904. doi:10.3969/j.issn.1000-6621.2019.08.018.
doi: 10.3969/j.issn.1000-6621.2019.08.018 URL |
[22] | 张娟娟, 胡方祥, 王云霞, 等. 2011—2015年深圳市宝安区结核病控制项目效果评价. 职业与健康, 2018, 34(7):946-949,953. |
[23] | 黄学贵, 刘国琴, 郁艳艳, 等. 贵州省结核病防治影响因素研究. 现代预防医学, 2014, 41(16): 3033-3035,3041. |
[24] |
管红云, 谭卫国, 杨应周, 等. 基于深圳市电子网络督导管理系统的肺结核患者管理治疗情况分析. 中国防痨杂志, 2017, 39(7):702-707. doi:10.3969/j.issn.1000-6621.2017.07.007.
doi: 10.3969/j.issn.1000-6621.2017.07.007 URL |
[1] | Guo Qiang, Li Ruiping, Ma Yubao, Zhang Lan, Yang Shumin. Analysis of treatment adverse outcomes for rifampicin sensitive pulmonary tuberculosis patients with random effects logistic model in Gansu Province from 2018 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(6): 455-462. |
[2] | Chen Zidan, Mao Ling. Clinical analysis of 28 cases of artificial stone associated silicosis complicated with pulmonary tuberculosis and non-tuberculous mycobacteria disease [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(5): 388-393. |
[3] | Dong Zhaoliang, Yao Liming, Li Lingdi, Wang Lianbo, Yao Xiaowei, Li Zhuo, Liu Fengsheng, Jia Chenguang. Clinical efficacy of conservative treatment for mild spinal tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(4): 281-286. |
[4] | Li Yishuai, Qin Xuebo, Li Xianglan, Wei Lan, Duan Xiaoliang, Zhang Lei, Chen Liang, Li Jianhang. Analysis of effect of video-assisted thoracoscopic surgery versus thoracotomy in the treatment of refractory cavity pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(4): 292-295. |
[5] | LI Yong, LU Li-ping, LI Jin, ZOU Jin-yan. Analysis of willingness and effect of tuberculosis assistant APP and electronic kit in pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(1): 22-26. |
[6] | WEI Jian-hua, GUO Tao, GAO Xiao-na, WU Wei, GUO Lei. Clinical characteristics and treatment outcome of 151 hospitalized students with tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(4): 330-335. |
[7] | LIAO Xiao-qin, LIN Jian-dong, WU Di, CHEN Xiao-hong. Analysis of the clinical characteristics of Mycobacterium avian complex pulmonary disease and the risk factors of treatment effect [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(2): 120-124. |
[8] | ZHONG Tao, WU Li-juan, FAN Yu-zheng, GUO Xu-jun, Wang Jian, LIU Sheng-yuan. Knowledge, attitude and practice towards tuberculosis prevention and control among elderly people in Nanshan district, Shenzhen: a cross-sectional study [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(2): 156-163. |
[9] | ZHANG Hong-wei, SUN Shan-hua, GAO Zhi-dong, XU Yan, TAO Li-ying, CHEN Xi. Treatment and outcomes of rifampicin-resistant pulmonary tuberculosis in Beijing, 2016—2020 [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(2): 164-168. |
[10] | GUO Qian, SHEN Chen. The progress of non-tuberculous mycobacterium disease in children [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(2): 184-188. |
[11] | XIAO Juan, PI Hong-lin, SUN Qing-peng. Analysis of clinical characteristics and therapeutic effect of 96 patients with spinal tuberculosis underwent surgical treatment [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 38-42. |
[12] | HUANG Jin-bao, LAN Chang-qing, LYU Xiao, CHEN Lu-lu, WANG Xin-hang, CHEN Yu-rong, HUANG Ming-xiang. Analysis of 23 cases of imported coronavirus disease 2019 [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 213-219. |
[13] | AN Hong-xia, YANG Feng-qin, LU Chuan, MA Xiu-xia. Analysis of the effect of extended nursing service by QQ group on health education for tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 265-269. |
[14] | JIN Min-lu, CHANG Yun-qing, QI Feng-ming, GUAN Xiao-gang, ZHENG Guan-hua, ZHAO Yong-hua, LI Zhen-qiang, LI Xiao-sheng, WANG Li-fen, WANG Fang, BAI Yin-jie. Clinical characteristics and effect analysis of 39 cases of 2019 novel Coronavirus-related pneumonia [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 131-135. |
[15] | WANG Li-hua, LIU Yan-yan. Clinical analysis of 27 neurobrucellosis cases misdiagnosed as tuberculosis meningitis [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 183-185. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||